BCL2 and cancer: Through the construction of a comprehensive PPI network and subsequent analysis using multiple bioinformatics tools (PINA, MOE, STRING, RING, and gProfiler), three key interactors (p53, RAF1, and MAPK1) were identified as crucial players in the cancer-related activity of BCL2.